GPhA Faces Transition After CEO Jaeger Resigns
This article was originally published in The Pink Sheet Daily
Executive Summary
With a smaller membership and a challenging new biosimilars pathway, association gears up for user fee negotiations with FDA.
You may also be interested in...
Kathleen Jaeger Joins NACDS In Pharmacy And Patient Advocacy Role
New position is first time Jaeger has not had CEO in her title since 2002. She also takes on presidency of NACDS Foundation.
Former GPhA Head Kathleen Jaeger To Take Over As CEO Of NCPA
Jaeger takes on role at National Community Pharmacists Association on Nov. 1, 2010, as the organization works with CMS on Medicaid generic pharmacy reimbursement regulations.
Former GPhA Head Kathleen Jaeger To Take Over As CEO Of NCPA
Jaeger takes on role at National Community Pharmacists Association on Nov. 1, 2010, as the organization works with CMS on Medicaid generic pharmacy reimbursement regulations.